The growth is attributed to the increasing population, rising awareness about maternal health, and improving healthcare infrastructure. The increasing number of government initiatives to reduce maternal mortality and morbidity rates is also expected to drive market growth. The higher female maternal mortality rates in the region are the major reason for the improvement of the basic maternity infrastructure in the region. For instance, as per the World Health Organization (WHO), 16% of global maternal death were reported in South Asia in 2020. The number accounted for 47000 deaths in 2020.

Access sample report (including graphs, charts, and figures): https://univdatos.com/report/carbetocin-market/get-a-free-sample-form.php?product_id=38919

Further, the Asia-Pacific Carbetocin Market is expected to grow at a strong CAGR of 8% during the forecast period (2022-2030). The rising awareness about the seriousness of maternal health, and increasing governmental efforts in improving the healthcare system for women.

 

APAC Carbetocin Market Revenue (2020-2030)- USD Mn

news-1.png

Based on type, the market is segmented into original drug and generic drug. As per our analysis, the diagnosis segment acquired a major share in 2021. Duratocin is the original and the most widely used brand of carbetocin, and it is available in many countries around the world. This is mainly due to the high popularity of the brand and the quality of the brand offered by the companies attributes to the large share of the segments.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://univdatos.com/report/carbetocin-market/

Based on the end-user, the market is segmented into hospitals, clinics, and others. As per our analysis, the hospitals held the dominant share in 2021. Carbetocin is a commonly used medication in obstetrics and is likely to be available in many hospitals worldwide, particularly those that provide maternity care. The hospitals are advancing their facilities and they have specialized departments for maternal care is the major reason for the large share of the hospital segment in the market.

Global Carbetocin Market Segmentation

Market Insight, by Type

  • Original Drug
  • Generic Drug

Market Insight, by End-User

  • Hospitals
  • Clinics
  • Others

Market Insight, by Region

  • North America U.S.
  •  Canada
  •  Rest of North America
  • EuropeGermany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • APACChina
  • Japan
  • India
  • Rest of APAC
  • Rest of the World

Top Company Profiles

• Ferring B.V.

• Hybio Pharmaceutical Co., Ltd.

• Pfizer Inc.

• Beacon Pharmaceuticals Limited

• SGPharma Pvt. Ltd.

• Taj Pharmaceuticals

• Abbott

• MANUS AKTTEVA BIOPHARMA LLP

• Enomark

• Sun Pharmaceutical Industries Ltd